Boston Financial Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,997
Closed -$504K 239
2019
Q3
$504K Buy
2,997
+40
+1% +$6.52K 0.03% 179
2019
Q2
$495K Hold
2,957
0.03% 182
2019
Q1
$433K Sell
2,957
-109
-4% -$15.8K 0.03% 201
2018
Q4
$410K Buy
3,066
+109
+4% +$17.9K 0.03% 201
2018
Q3
$563K Hold
2,957
0.03% 200
2018
Q2
$493K Buy
+2,957
New +$475K 0.03% 186

Other funds holding AGN

Boston Financial Management's AGN Position: Q4 2019 in Review

Boston Financial Management sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 2,997 shares — an estimated $504K sold.

Boston Financial Management first reported a position in AGN in Q2 2018 and held it in 6 quarters. The position peaked at $563K in Q3 2018. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • Boston Financial Management reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
  • Boston Financial Management sold 2,997 Allergan plc shares in Q4 2019, an estimated $504K.
  • Boston Financial Management first reported a position in Allergan plc in Q2 2018 and held it in 6 quarters.
  • Boston Financial Management's Allergan plc position peaked at $563K in Q3 2018.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on Boston Financial Management's 13F filing for Q4 2019, filed 5 Feb 2020.